Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ATEKNASDAQ:CRTXNASDAQ:HSTMNASDAQ:OMCL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATEKAthena Technology Acquisition$10.00$9.73$1.00▼$13.41$101.50M0.374,188 shsN/ACRTXCortexyme$1.38-3.5%$1.07$1.78▼$40.66$41.61M1.4620,672 shs214,717 shsHSTMHealthStream$27.39-0.4%$29.70$25.84▼$34.24$831.81M0.43151,132 shs210,206 shsOMCLOmnicell$28.49-2.5%$29.66$22.66▼$55.75$1.37B0.78575,424 shs414,935 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATEKAthena Technology Acquisition0.00%0.00%0.00%+66.67%-11.50%CRTXCortexyme0.00%+22.22%+68.24%+3.62%+101.41%HSTMHealthStream+0.95%-2.52%-3.44%-12.30%-0.65%OMCLOmnicell-0.10%-7.77%+4.51%-11.27%+4.69%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATEKAthena Technology AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACRTXCortexymeN/AN/AN/AN/AN/AN/AN/AN/AHSTMHealthStream4.2458 of 5 stars2.43.01.74.82.33.30.6OMCLOmnicell3.1417 of 5 stars4.32.00.00.01.61.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATEKAthena Technology Acquisition 0.00N/AN/AN/ACRTXCortexyme 0.00N/AN/AN/AHSTMHealthStream 2.80Moderate Buy$31.5015.01% UpsideOMCLOmnicell 2.57Moderate Buy$44.8357.37% UpsideCurrent Analyst Ratings BreakdownLatest ATEK, CRTX, OMCL, and HSTM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/23/2025OMCLOmnicellPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight5/23/2025OMCLOmnicellBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$30.00 ➝ $34.005/23/2025OMCLOmnicellWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$35.00 ➝ $37.005/15/2025HSTMHealthStreamCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$30.00 ➝ $29.005/14/2025OMCLOmnicellWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$31.00 ➝ $35.005/7/2025OMCLOmnicellBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$62.00 ➝ $40.005/7/2025OMCLOmnicellWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$38.00 ➝ $31.004/17/2025OMCLOmnicellWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$40.00 ➝ $38.003/20/2025OMCLOmnicellJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$44.00 ➝ $36.00(Data available from 6/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATEKAthena Technology AcquisitionN/AN/AN/AN/AN/AN/ACRTXCortexymeN/AN/AN/AN/A$3.97 per shareN/AHSTMHealthStream$291.65M2.87$2.44 per share11.24$11.81 per share2.32OMCLOmnicell$1.11B1.20$2.98 per share9.56$26.84 per share1.06Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATEKAthena Technology AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ACRTXCortexyme-$89.94M-$2.97N/AN/AN/AN/A-70.96%-63.53%N/AHSTMHealthStream$20.01M$0.6343.4842.803.556.54%5.36%3.75%7/28/2025 (Estimated)OMCLOmnicell$12.53M$0.4661.9422.98N/A1.87%4.60%2.56%7/30/2025 (Estimated)Latest ATEK, CRTX, OMCL, and HSTM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025OMCLOmnicell$0.16$0.26+$0.10-$0.15$260.18 million$269.67 million5/5/2025Q1 2025HSTMHealthStream$0.16$0.14-$0.02$0.14$74.93 million$73.49 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATEKAthena Technology AcquisitionN/AN/AN/AN/AN/ACRTXCortexymeN/AN/AN/AN/AN/AHSTMHealthStream$0.120.44%N/A19.05%2 YearsOMCLOmnicellN/AN/AN/AN/AN/ALatest ATEK, CRTX, OMCL, and HSTM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2025HSTMHealthStreamquarterly$0.03100.37%5/19/20255/19/20255/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATEKAthena Technology AcquisitionN/AN/AN/ACRTXCortexymeN/A9.929.92HSTMHealthStreamN/A1.351.35OMCLOmnicell0.131.381.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATEKAthena Technology Acquisition17.30%CRTXCortexyme63.18%HSTMHealthStream69.58%OMCLOmnicell97.70%Insider OwnershipCompanyInsider OwnershipATEKAthena Technology Acquisition88.40%CRTXCortexyme27.90%HSTMHealthStream20.60%OMCLOmnicell2.52%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATEKAthena Technology Acquisition2,02110.15 million1.18 millionOptionableCRTXCortexyme5530.15 million21.74 millionNot OptionableHSTMHealthStream1,09330.52 million24.24 millionOptionableOMCLOmnicell3,67046.84 million45.66 millionOptionableATEK, CRTX, OMCL, and HSTM HeadlinesRecent News About These CompaniesQ1 Rundown: Omnicell (NASDAQ:OMCL) Vs Other Healthcare Technology for Providers StocksJune 17 at 11:56 AM | msn.comGAMMA Investing LLC Has $1.51 Million Holdings in Omnicell, Inc. (NASDAQ:OMCL)June 15 at 3:39 AM | marketbeat.comDo Options Traders Know Something About Omnicell Stock We Don't?June 13, 2025 | msn.comOmnicell to pay $4.3M for overbilling VA in SpokaneJune 11, 2025 | khq.com1 Cash-Producing Stock with Promising Prospects and 2 to Keep Off Your RadarJune 9, 2025 | msn.comIs it Apt to Retain Omnicell Stock in Your Portfolio Now?June 6, 2025 | zacks.comOmnicell, Inc. (NASDAQ:OMCL) Sees Significant Decrease in Short InterestJune 6, 2025 | marketbeat.comOmnicell CFO Nchacha Etta to Step DownJune 5, 2025 | tipranks.comOmnicell (OMCL) Up 27% Since Last Earnings Report: Can It Continue?June 5, 2025 | zacks.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Position in Omnicell, Inc. (NASDAQ:OMCL)June 3, 2025 | marketbeat.comWellington Management Group LLP Has $14.49 Million Stock Holdings in Omnicell, Inc. (NASDAQ:OMCL)June 2, 2025 | marketbeat.comNuveen Asset Management LLC Trims Stock Position in Omnicell, Inc. (NASDAQ:OMCL)May 30, 2025 | marketbeat.comBNP Paribas Financial Markets Lowers Position in Omnicell, Inc. (NASDAQ:OMCL)May 29, 2025 | marketbeat.comOmnicell, Inc. (NASDAQ:OMCL) Given Average Recommendation of "Moderate Buy" by BrokeragesMay 29, 2025 | marketbeat.comTwo Sigma Investments LP Boosts Stock Position in Omnicell, Inc. (NASDAQ:OMCL)May 28, 2025 | marketbeat.comOmnicell, Inc. (NASDAQ:OMCL) Shares Acquired by Squarepoint Ops LLCMay 27, 2025 | marketbeat.comAmeriprise Financial Inc. Trims Stake in Omnicell, Inc. (NASDAQ:OMCL)May 26, 2025 | marketbeat.comOmnicell (NASDAQ:OMCL) Stock Price Expected to Rise, Bank of America Analyst SaysMay 25, 2025 | marketbeat.comWells Fargo & Company Issues Positive Forecast for Omnicell (NASDAQ:OMCL) Stock PriceMay 25, 2025 | marketbeat.comOmnicell, Inc. (NASDAQ:OMCL) Stock Holdings Increased by Deutsche Bank AGMay 25, 2025 | marketbeat.comOmnicell (NASDAQ:OMCL) Shares Gap Up - Here's What HappenedMay 24, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeATEK, CRTX, OMCL, and HSTM Company DescriptionsAthena Technology Acquisition NYSE:ATEKAthena Technology Acquisition Corp. is a blank check company. The company was incorporated in 2020 and is based in Kennesaw, Georgia.Cortexyme NASDAQ:CRTX$1.38 -0.05 (-3.50%) As of 06/16/2025Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.HealthStream NASDAQ:HSTM$27.39 -0.12 (-0.44%) Closing price 04:00 PM EasternExtended Trading$27.38 -0.01 (-0.04%) As of 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs. It offers hStream, a technology platform that powers a range of healthcare workforce solutions. The company provides its solutions to customers across a range of entities within the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through its direct sales teams. The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.Omnicell NASDAQ:OMCL$28.49 -0.73 (-2.50%) Closing price 04:00 PM EasternExtended Trading$27.80 -0.69 (-2.42%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analyst Downgrades Joby, But Overlooks Major Regulatory Wins Applied Digital: Now the High-Stakes Race to Build Begins Zscaler Upgraded: Wall Street Forecasts 26% More Upside U.S. Steel Stock Burns the Bears With Surprise Upside Move Is CrowdStrike Stock Set to Break Out or Cool Off? New Catalysts to Drive NVIDIA’s Stock Price Even Higher Palantir Defies Bears, Leads S&P 500 in 2025 The Bottom Is in for Powerfleet: An Intelligent Time to Buy Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
